Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA04 - Novel Approaches with IO
- 13:30 - 15:00
- 9/24/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA04.08 - Discussant - MA 04.05, MA 04.06, MA 04.07
14:15 - 14:30 | Presenter: Patrick M Forde
- Abstract
No abstract available for this presentation
-
+
MA04.11 - Neoantigen Targeting and T Cell Reshaping in Resectable NSCLC Patients Treated with Neoadjuvant PD-1 Blockade
14:40 - 14:45 | Presenter: Kellie Nicole Smith | Author(s): Margueritta El Asmar, Jiajia Zhang, Justina X Caushi, Zhicheng Ji, Valsamo Anagnostou, Tricia R Cottrell, Hok Yee Chan, Prerna Suri, Haidan Guo, Kristen A. Marrone, Jarushka Naidoo, Taha Merghoub, Jamie E Chaft, Matthew D. Hellmann, Janis M Taube, Julie R. Brahmer, Patrick M Forde, Victor Velculescu, Drew M Pardoll, Hongkai Ji
- Abstract
Loading...
-
+
P2.01 - Advanced NSCLC (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.01-33 - Open-Label, Biomarker-Directed Platform Study in NSCLC Patients Who Progressed on an Anti-PD-(L)1 Containing Therapy (HUDSON)
16:45 - 18:00 | Presenter: Patrick M Forde | Author(s): John V Heymach, Michael Thomas, Keunchil Park, Benjamin Besse, Mark M. Awad, Glenwood Goss, Naiyer A Rizvi, Helen J Ambrose, Philip John Jewsbury, Barbara Koetz, Si-Houy Lao-Sirieix, Peter G Mortimer, Sabina I Patel, Kris Sachsenmeier, Wolfram Brugger
- Abstract
Loading...
-
+
P2.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session)
- 16:45 - 18:00
- 9/25/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P2.16-03 - CheckMate 816: A Phase 3 Trial of Neoadjuvant Nivolumab Plus Ipilimumab or Chemotherapy vs Chemotherapy in Early-Stage NSCLC
16:45 - 18:00 | Presenter: Enriqueta Felip | Author(s): Julie R. Brahmer, Stephen Broderick, Scott Swanson, Mark M. Awad, Tetsuya Mitsudomi, Nicolas Girard, Keith M Kerr, Jonathan David Spicer, Junliang Cai, Rong Yang, Patrick M Forde
- Abstract
Loading...